Blood News and Research

RSS

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces that The Lancet has published the results of its Phase 2 clinical trial of its lead candidate, EMA401, in postherpetic neuralgia (PHN).

5 Feb 2014

Findings raise hope for new oral anticoagulants to treat patients with atrial fibrillation

Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most widely prescribed oral-anticoagulant therapy, according to a study published online in Circulation, the journal of the American Heart Association.

From Quest Diagnostics 5 Feb 2014

New MRI can predict which atrial fibrillation patients are most likely to benefit from catheter ablation

A new type of contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from a treatment called catheter ablation, according to a landmark multi-center study published in the Journal of the American Medical Association.

5 Feb 2014

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

A UT Arlington bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease.

5 Feb 2014

Researchers identify specific biomarkers of obesity and early-stage colon cancer

Obesity is a known risk factor for many cancers including colon cancer, yet the reasons behind the colon cancer link have often remained unclear.

5 Feb 2014

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.

5 Feb 2014

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease.

5 Feb 2014

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to standard antiepileptic drugs.

5 Feb 2014

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

5 Feb 2014

FDA approves new artificial heart valve device that does not require major open surgery

An artificial heart valve device that does not require major open surgery has been approved by the Food and Drug Administration.

From Medtronic 5 Feb 2014

Added sugar increases risk of dying from cardiovascular disease

According to the study published in JAMA: Internal Medicine, those who got 17 to 21 percent of calories from added sugar had a 38 percent high risk of dying from cardiovascular disease compared to those who consumed 8 percent of their calories from added sugar.

5 Feb 2014

Blood disorder medicines could be used for treating stomach and bowel cancer

Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.

5 Feb 2014

Professor wins Wiley Prize for discovering how cells sense, respond to low oxygen conditions

The 13th annual Wiley Prize in Biomedical Sciences was awarded to Gregg Semenza, M.D., Ph.D., for his contribution to discovering how cells sense and respond to low oxygen conditions.

5 Feb 2014

Scientists use SWI to study changes in brains of college-level ice hockey players with concussion

Using susceptibility-weighted imaging (SWI), researchers have identified microstructural changes in the brains of male and female college-level ice hockey players that could be due to concussive or subconcussive trauma.

4 Feb 2014

Researchers discover genetic mutations that cause deadly lung disease

A team of researchers, led by physicians and scientists at Intermountain Medical Center and ARUP Laboratories in Salt Lake City, has made a medical breakthrough by discovering genetic mutations that cause a rare and deadly lung disease.

4 Feb 2014

Study analyzing concussion data for NFL players may provide insight that could lead to safer play

A new study analyzing concussion data for NFL players during the16-game regular season schedules for 2012 and 2013 may provide insight that could lead to safer play, including a pathway for concussion-prevention strategies.

4 Feb 2014

Researchers develop rehydration beverage to treat hypohydration in astronauts

How is living in space like playing in the Super Bowl? Both involve circumstances that cause the body to involuntarily lose water. Astronauts and athletes with low body water can suffer physical performance impairments and can develop symptoms such as headaches, fatigue, muscle cramps, light headedness, disorientation and, in severe cases, loss of consciousness.

4 Feb 2014

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.

4 Feb 2014

Researchers recommend FIT as screening tool for colorectal cancer

Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine.

4 Feb 2014

Gene involved in inflammation, blood clotting associated with cerebral palsy, death in very preterm babies

In a study to be presented on Feb. 6 at 2:45 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that a variant in SERPINE1, a gene involved in inflammation and blood clotting, is associated with cerebral palsy and death in very preterm babies.

4 Feb 2014

Blood News and Research

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Findings raise hope for new oral anticoagulants to treat patients with atrial fibrillation

New MRI can predict which atrial fibrillation patients are most likely to benefit from catheter ablation

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

Researchers identify specific biomarkers of obesity and early-stage colon cancer

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

FDA approves new artificial heart valve device that does not require major open surgery

Added sugar increases risk of dying from cardiovascular disease

Blood disorder medicines could be used for treating stomach and bowel cancer

Professor wins Wiley Prize for discovering how cells sense, respond to low oxygen conditions

Scientists use SWI to study changes in brains of college-level ice hockey players with concussion

Researchers discover genetic mutations that cause deadly lung disease

Study analyzing concussion data for NFL players may provide insight that could lead to safer play

Researchers develop rehydration beverage to treat hypohydration in astronauts

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Researchers recommend FIT as screening tool for colorectal cancer

Gene involved in inflammation, blood clotting associated with cerebral palsy, death in very preterm babies

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News